Design, synthesis and in vitro anti-proliferative evaluation of new pyridine-2,3-dihydrothiazole/thiazolidin-4-one hybrids as dual CDK2/GSK3β kinase inhibitors.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/39376524

Aisha A K Al-Ashmawy; Ashraf A Sediek; Asmaa F Kassem; Doaa S Foda; Mervat M Omran

Oct 8, 2024